BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

867 related articles for article (PubMed ID: 31880071)

  • 1. Bone Turnover Markers and Bone Mineral Density to Predict Osteoporotic Fractures in Older Women: A Retrospective Comparative Study.
    Qu XL; Zheng B; Chen TY; Cao ZR; Qu B; Jiang T
    Orthop Surg; 2020 Feb; 12(1):116-123. PubMed ID: 31880071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
    Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
    Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort.
    Yoshimura N; Muraki S; Oka H; Kawaguchi H; Nakamura K; Akune T
    Mod Rheumatol; 2011 Dec; 21(6):608-20. PubMed ID: 21512822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between bone mineral density and bone metabolic markers in postmenopausal women with osteoporotic fractures at different C-terminal telopeptide of type 1 collagen levels: a retrospective analysis study.
    Zhu X; Chen L; Pan L; Zeng Y; Fu Q; Liu Y; Peng Y; Wang Y; You L
    Menopause; 2023 Nov; 30(11):1139-1146. PubMed ID: 37847873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone turnover markers are associated with higher cortical porosity, thinner cortices, and larger size of the proximal femur and non-vertebral fractures.
    Shigdel R; Osima M; Ahmed LA; Joakimsen RM; Eriksen EF; Zebaze R; Bjørnerem Å
    Bone; 2015 Dec; 81():1-6. PubMed ID: 26112819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of changes in serum high t-PINP/β-CTX ratio and risk of re-fracture after vertebral osteoporotic fracture surgery.
    Lin XB; Ye H; He LJ; Xu ZB
    Eur Rev Med Pharmacol Sci; 2023 Nov; 27(22):10860-10867. PubMed ID: 38039015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin and bone status in men: analysis of the MINOS cohort.
    Breuil V; Fontas E; Chapurlat R; Panaia-Ferrari P; Yahia HB; Faure S; Euller-Ziegler L; Amri EZ; Szulc P
    Osteoporos Int; 2015 Dec; 26(12):2877-82. PubMed ID: 26109496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship of iron overload to bone mass density and bone turnover in postmenopausal women with fragility fractures of the hip].
    Zhang LL; Jiang XF; Ai HZ; Jin ZD; Xu JX; Wang B; Xu W; Xie ZG; Zhou HB; Dong QR; Xu YJ
    Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):518-21. PubMed ID: 24091266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial.
    Bauer DC; Garnero P; Hochberg MC; Santora A; Delmas P; Ewing SK; Black DM;
    J Bone Miner Res; 2006 Feb; 21(2):292-9. PubMed ID: 16418785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome.
    Cortet B; Cortet C; Blanckaert F; d'Herbomez M; Marchandise X; Wémeau J-L ; Decoulx M; Dewailly D
    Osteoporos Int; 2001; 12(2):117-23. PubMed ID: 11303711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
    Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
    Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Tamaki J; Iki M; Kadowaki E; Sato Y; Chiba Y; Akiba T; Matsumoto T; Nishino H; Kagamimori S; Kagawa Y; Yoneshima H;
    Osteoporos Int; 2013 Mar; 24(3):887-97. PubMed ID: 22885773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
    Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
    J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical value of serum total P1NP, β-CTX and 25(OH)D3 detection in evaluating risks of fragile hip fracture in elderly patients with osteoporosis].
    Lou H; Peng C; Chen Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1346-9. PubMed ID: 22985580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
    Nguyen LT; Nguyen UDT; Nguyen TDT; Ho-Pham LT; Nguyen TV
    Osteoporos Int; 2018 Dec; 29(12):2739-2744. PubMed ID: 30196375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women.
    Bruyere O; Collette J; Delmas P; Rouillon A; Roux C; Seidel L; Richy F; Reginster JY
    Maturitas; 2003 Apr; 44(4):259-65. PubMed ID: 12697366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus.
    Jiajue R; Jiang Y; Wang O; Li M; Xing X; Cui L; Yin J; Xu L; Xia W
    Osteoporos Int; 2014 Aug; 25(8):1999-2005. PubMed ID: 24760246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study.
    Bønløkke SE; Rand MS; Haddock B; Arup S; Smith CD; Jensen JEB; Schwarz P; Hovind P; Oturai PS; Jensen LT; Møller S; Eiken P; Rubin KH; Hitz MF; Abrahamsen B; Jørgensen NR
    Osteoporos Int; 2022 Oct; 33(10):2155-2164. PubMed ID: 35729342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of PFN1 Gene Polymorphisms with Bone Mineral Density, Bone Turnover Markers, and Osteoporotic Fractures in Chinese Population.
    Wu Y; Wu S; Yang E; Zhang G; Shi Q; Liang J; Lian X; Xu J
    Calcif Tissue Int; 2023 Aug; 113(2):207-215. PubMed ID: 37401976
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 44.